Medicenna Therapeutics Corp. (MDNAF)
OTCMKTS · Delayed Price · Currency is USD
0.7660
+0.0620 (8.81%)
May 9, 2025, 4:00 PM EDT

Medicenna Therapeutics Market Cap

Medicenna Therapeutics has a market cap or net worth of $63.39 million as of May 9, 2025. Its market cap has decreased by -36.06% in one year.

Market Cap
63.39M
Enterprise Value
41.99M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.77

Market Cap Chart

Since March 8, 2017, Medicenna Therapeutics's market cap has increased from 48.70M to 63.39M, an increase of 30.15%. That is a compound annual growth rate of 3.28%.

History

DateMarket Cap% Change
May 9, 202563.39M-29.33%
Dec 31, 202489.69M305.00%
Dec 29, 202322.15M-32.75%
Dec 30, 202232.93M-63.24%
Dec 31, 202189.58M-62.05%
Dec 31, 2020236.06M163.81%
Dec 31, 2019 Pro Pro
Dec 31, 2018 Pro Pro
Dec 29, 2017 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Endo Inc. 1.60B
Nika Pharmaceuticals 1.02B
Veradigm 761.86M
Tian'an Technology Group 568.98M
Glass House Brands 485.08M
Elite Pharmaceuticals 448.25M
CytoDyn 417.40M
Northwest Biotherapeutics 389.52M
Market Cap Rankings